Trial Profile
Active-controlled trial of the safety and tolerability of MP03-33 in patients with chronic allergic or nonallergic rhinitis
Status:
Active, no longer recruiting
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 21 Mar 2007
Price :
$35
*
At a glance
- Drugs Azelastine (Primary)
- Indications Allergic rhinitis; Rhinitis
- Focus Adverse reactions
- 21 Mar 2007 New trial record.